Cargando…

Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency

BACKGROUND: Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Castiello, Maria Carmina, Bosticardo, Marita, Sacchetti, Nicolò, Calzoni, Enrica, Fontana, Elena, Yamazaki, Yasuhiro, Draghici, Elena, Corsino, Cristina, Bortolomai, Ileana, Sereni, Lucia, Yu, Hsin-Hui, Uva, Paolo, Palchaudhuri, Rahul, Scadden, David T., Villa, Anna, Notarangelo, Luigi D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322962/
https://www.ncbi.nlm.nih.gov/pubmed/32387109
http://dx.doi.org/10.1016/j.jaci.2020.04.033
_version_ 1783731152372105216
author Castiello, Maria Carmina
Bosticardo, Marita
Sacchetti, Nicolò
Calzoni, Enrica
Fontana, Elena
Yamazaki, Yasuhiro
Draghici, Elena
Corsino, Cristina
Bortolomai, Ileana
Sereni, Lucia
Yu, Hsin-Hui
Uva, Paolo
Palchaudhuri, Rahul
Scadden, David T.
Villa, Anna
Notarangelo, Luigi D.
author_facet Castiello, Maria Carmina
Bosticardo, Marita
Sacchetti, Nicolò
Calzoni, Enrica
Fontana, Elena
Yamazaki, Yasuhiro
Draghici, Elena
Corsino, Cristina
Bortolomai, Ileana
Sereni, Lucia
Yu, Hsin-Hui
Uva, Paolo
Palchaudhuri, Rahul
Scadden, David T.
Villa, Anna
Notarangelo, Luigi D.
author_sort Castiello, Maria Carmina
collection PubMed
description BACKGROUND: Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation. OBJECTIVES: Our aim was to improve multilineage engraftment; we tested nongenotoxic conditioning with anti-CD45 mAbs conjugated with saporin CD45 (CD45-SAP). METHODS: Rag1-KO and Rag1-F971L mice, which represent models of severe combined immune deficiency and combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI, or no conditioning and treated by using transplantation with lineage-negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to 2,4,6-trinitrophenyl–conjugated keyhole limpet hemocyanin were measured by ELISA, and presence of autoantibody was detected by microarray. RESULTS: Conditioning with CD45-SAP enabled high levels of multilineage engraftment in both Rag1 mutant models, allowed overcoming of B- and T-cell differentiation blocks and thymic epithelial cell defects, and induced robust cellular and humoral immunity in the periphery. CONCLUSIONS: Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic Rag mutations while preserving thymic epithelial cell homeostasis.
format Online
Article
Text
id pubmed-8322962
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-83229622021-07-30 Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency Castiello, Maria Carmina Bosticardo, Marita Sacchetti, Nicolò Calzoni, Enrica Fontana, Elena Yamazaki, Yasuhiro Draghici, Elena Corsino, Cristina Bortolomai, Ileana Sereni, Lucia Yu, Hsin-Hui Uva, Paolo Palchaudhuri, Rahul Scadden, David T. Villa, Anna Notarangelo, Luigi D. J Allergy Clin Immunol Article BACKGROUND: Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation. OBJECTIVES: Our aim was to improve multilineage engraftment; we tested nongenotoxic conditioning with anti-CD45 mAbs conjugated with saporin CD45 (CD45-SAP). METHODS: Rag1-KO and Rag1-F971L mice, which represent models of severe combined immune deficiency and combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI, or no conditioning and treated by using transplantation with lineage-negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to 2,4,6-trinitrophenyl–conjugated keyhole limpet hemocyanin were measured by ELISA, and presence of autoantibody was detected by microarray. RESULTS: Conditioning with CD45-SAP enabled high levels of multilineage engraftment in both Rag1 mutant models, allowed overcoming of B- and T-cell differentiation blocks and thymic epithelial cell defects, and induced robust cellular and humoral immunity in the periphery. CONCLUSIONS: Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic Rag mutations while preserving thymic epithelial cell homeostasis. 2020-05-06 2021-01 /pmc/articles/PMC8322962/ /pubmed/32387109 http://dx.doi.org/10.1016/j.jaci.2020.04.033 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Castiello, Maria Carmina
Bosticardo, Marita
Sacchetti, Nicolò
Calzoni, Enrica
Fontana, Elena
Yamazaki, Yasuhiro
Draghici, Elena
Corsino, Cristina
Bortolomai, Ileana
Sereni, Lucia
Yu, Hsin-Hui
Uva, Paolo
Palchaudhuri, Rahul
Scadden, David T.
Villa, Anna
Notarangelo, Luigi D.
Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
title Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
title_full Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
title_fullStr Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
title_full_unstemmed Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
title_short Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
title_sort efficacy and safety of anti-cd45–saporin as conditioning agent for rag deficiency
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322962/
https://www.ncbi.nlm.nih.gov/pubmed/32387109
http://dx.doi.org/10.1016/j.jaci.2020.04.033
work_keys_str_mv AT castiellomariacarmina efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT bosticardomarita efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT sacchettinicolo efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT calzonienrica efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT fontanaelena efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT yamazakiyasuhiro efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT draghicielena efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT corsinocristina efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT bortolomaiileana efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT serenilucia efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT yuhsinhui efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT uvapaolo efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT palchaudhurirahul efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT scaddendavidt efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT villaanna efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency
AT notarangeloluigid efficacyandsafetyofanticd45saporinasconditioningagentforragdeficiency